About 400 reports

  • Autoimmune diseases
  • Localized autoimmune disease diagnostics

About the Autoimmune Disease Diagnostics Market Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized...

  • Autoimmune Disease
  • World
  • Abbott Laboratories, Inc.
  • EUROIMMUN AG
  • Roche Group

Autoimmune Disease Diagnostics Market: The global Industry Analysis, Trends, Market Size and Forecasts up to 2023 ##.

  • Autoimmune Disease
  • Diagnostics
  • World
  • Market Size

## Country share estimation TABLE ## List of NIH funding programs, 2013 TABLE ## Potential biomarkers and their potential applications in treating SLE TABLE ## ITP prevalence, by condition TABLE ## North America autoimmune disease diagnostics market, by type, 2013 - 2025 (USD M

  • Autoimmune Disease
  • Diagnostics
  • Pathology
  • United States
  • Market Size

Autoimmune Disease Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 ##.

  • Autoimmune Disease
  • Diagnostics
  • Pathology
  • World
  • Market Size

Lab Test IVD for Autoimmune Disease Diagnostics Market- SWOT Analysis, by Factor ##. ## Industry Analysis - Porter’s ##. ## Technology Trends ##. ## Competitive Analysis/ Heat Map Analysis 2015 Chapter ## Market Categorization ##: Application Estimates & Trend Analysis ##. ## U.

  • Autoimmune Disease
  • Diagnostics
  • United States
  • Forecast
  • Market Size
  • RISING PREVALENCE OF AUTOIMMUNE DISEASES
  • AUTOIMMUNE DISEASES 2015-2020

About Autoimmune Diseases Drugs Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal...

  • Autoimmune Disease
  • World
  • Biogen Idec Inc.
  • Pfizer Inc.
  • Remicade group

Rising healthcare expenditure in the region is one of the key factors fueling the market growth.

  • Autoimmune Disease
  • Pathology
  • APAC
  • World
  • Forecast
  • 06.1 UNDERSTANDING AUTOIMMUNE DISEASES
  • Autoimmune Diseases Drugs Market in the US

About Autoimmune Diseases Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation,...

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.

Analysis of the US Autoimmune Disease Diagnostics Market ## ANALYSIS OF THE US AUTOIMMUNE DISEASE DIAGNOSTICS MARKET Executive Summary ## Scope and Segmentation ## Key Predictions: US Autoimmune Disease Diagnostics Market ## Curr

  • Autoimmune Disease
  • Diagnostics
  • United States
  • Forecast
  • Market Size
  • MARKET SEGMENTATION OF GLOBAL AUTOIMMUNE DISEASE MARKET BY DRUG CLASS
  • Identifying Factors Impacting Market Growth

About Anti-Inflammatory Therapeutics Inflammation is a part of immune response triggered against harmful stimuli, foreign objects, damaged cells, irritants, and pathogens in the body. The drugs used to treat these symptoms are called anti-inflammatory drugs. It causes the elimination of the initial cause of cell injury, clearance...

  • Autoimmune Disease
  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • PROTEOMICS APPROACH: AUTOIMMUNE DISEASE BIOMARKER DISCOVERY
  • AUTOIMMUNE DISORDERS

The biomarker technologies market is projected to grow at a CAGR of 9.7%. The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period The growth of this market is mainly driven by increasing healthcare expenditure and...

  • Autoimmune Disease
  • North America
  • United States
  • World
  • Market Size
  • Increased prevalence of autoimmune diseases
  • Limitations of autoimmune disease diagnostics

About Anti-Nuclear Antibody (ANA) Testing Antibodies that attack healthy proteins in the nucleus cells are called antinuclear antibodies. When a person has an autoimmune disease such as rheumatoid arthritis or systemic lupus erythematosus (SLE), the immune system produces antibodies that will attach to the cells, often causing...

  • Autoimmune Disease
  • Forecast
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Thermo Fisher Scientific, Inc.
  • GROWING PREVALENCE OF CANCER AND AUTOIMMUNE DISEASES
  • HIGH COSTS OF BIOLOGICALS

About Immunohematology Blood loss or anemia can lead to chronic health problems; therefore, clinicians performs blood transfusion that can help to get relief from chronic health problems. To transfuse, blood clinicians or hospitals take blood units present in their own integrated blood banks or from other centers. Immunohematology,...

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • AUTOIMMUNE DISEASES
  • GLOBAL IMMUNOSUPPRESSANTS MARKET

About Immunology The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the...

  • Autoimmune Disease
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • GLOBAL SCLERODERMA TREATMENT MARKET BY OTHERS DRUG CLASS 2016-2021 ($ MILLIONS)
  • INTRODUCTION OF STEM CELLS IN SCLERODERMA TREATMENT

Autoimmune diseases such as scleroderma are chronic, and they affect multiple organs.

  • Autoimmune Disease
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • INCREASE IN PUBLIC AWARENESS PROGRAMS
  • Global Vasculitis Treatment Market is Expected to Grow to $517.64 mn by 2021

About Vasculitis Treatment Vasculitis is an autoimmune disorder that causes inflammation of the blood vessels. The body’s immune system attacks the blood vessels, which results in inflammation. When this inflammation occurs, the walls of the affected blood vessels get thicker and the passages through which the blood flows get...

  • Autoimmune Disease
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • 8.5.2 HOSPIRA'S INFLECTRA VERSUS J&J'S REMICADE IN KEY AUTOIMMUNE DISEASES
  • PROVIDES A SWOT ANALYSIS OF ELI LILLY'S PSORIASIS PORTFOLIO.

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report....

  • Autoimmune Disease
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG

The diagnosed prevalent cases are further segmented by severity (mild to moderate, moderate to severe, and severe to fulminant) and by comorbid autoimmune diseases (psoriasis, ankylosing spondylitis, and pyodermagangrenosum).

  • Autoimmune Disease
  • Digestive System Disorder
  • United States
  • World
  • Forecast
  • GROWING PREVALENCE OF CANCER AND AUTOIMMUNE DISEASES
  • HIGH COSTS OF BIOLOGICALS

About Immunotherapy Drugs Immunotherapy enhances the innate powers of the immune system. The properties of the immune system to fight abnormal cells give immunotherapy drugs the chance of successfully fighting diseases such as cancer, respiratory, infectious, and autoimmune disorders. Technavio’s analysts forecast the global...

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • BASED ON THE TYPE OF DISEASE, THE GLOBAL MUSCULOSKELETAL DISORDER THERAPEUTICS MARKET CAN BE SEGMENTED AS FOLLOWS:
  • Market segmentation by disease type

About Musculoskeletal Disorders Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range...

  • Autoimmune Disease
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly & Co.
  • 7.5.2 Hospira's Inflectra Versus J&J's Remicade in Key Autoimmune Diseases
  • Stelara SWOT Analysis, 2015

Psoriasis - US Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening,...

  • Autoimmune Disease
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 7.5.2 Hospira's Inflectra Versus J&J's Remicade in Key Autoimmune Diseases
  • Cosentyx SWOT Analysis, 2015

Psoriasis - Japan Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not...

  • Autoimmune Disease
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 7.5.2 Hospira's Inflectra Versus J&J's Remicade in Key Autoimmune Diseases
  • Stelara SWOT Analysis, 2015

Psoriasis - 5EU Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening,...

  • Autoimmune Disease
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 7.5.2 Hospira's Inflectra Versus J&J's Remicade in Key Autoimmune Diseases
  • Cosentyx SWOT Analysis, 2015

Psoriasis - India Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not...

  • Autoimmune Disease
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 2.1.2 SYSTEMIC LUPUS ERYTHEMATOSUS
  • 2.3 Etiology and Pathophysiology

The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis.

  • Autoimmune Disease
  • World
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson
  • 7.2.3 CELLTRION INC. - MAJOR BIOSIMILARS APPROVED FOR MARKETING
  • 5.4 CHRONIC AND AUTOIMMUNE DISORDERS BIOSIMILARS MARKET AND FORECAST

In the next few years several major biologicals in oncology and the treatment of autoimmune diseases, accounting for more than Euros ## billion in spending, will lose their patent protection, opening the door to biosimilars.

  • Autoimmune Disease
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

Abstract Psoriasis (PsO) is a chronic autoimmune disease that results from the overproduction of skin cells that causes redness and inflammation.

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • World

Therefore, the market is segmented by diseases.

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • World

Both diseases affect the GI system with similar symptoms while the course of the diseases and treatments may be different.

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • World

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Ankylosing Spondylitis Market by Segment, U. S., ##

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • World